Alterity Therapeutics Debt-to-Assets Ratio Growth & History (ATHE)

Alterity Therapeutics's debt-to-assets ratio was 0.00 for fiscal 2026.

View full Alterity Therapeutics company overview

Alterity Therapeutics annual debt-to-assets ratio history

Alterity Therapeutics annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20262026-06-300.000.00+24.47%
20252025-06-300.00−0.00−59.18%
20242024-06-300.010.00+7.43%
20232023-06-300.010.00+171.13%
20222022-06-300.000.00+45.32%
20212021-06-300.00−0.00−42.61%
20202020-06-300.00−0.00−37.51%
20192019-06-300.01

Alterity Therapeutics debt-to-assets ratio trends

Over the last five fiscal years, Alterity Therapeutics's debt-to-assets ratio increased from 0.00 to 0.00, a change of 0.00. The latest reported quarter, Q4 2026, shows 0.00.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Alterity Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about ATHE yet. Start the conversation.

Write the first post